In related news, the American Diabetes Association released new consensus considerations and good-practice points for use of ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Study participants were randomly assigned 2:1 to receive once-weekly subcutaneous semaglutide 2.4mg or placebo alongside standard of care. The primary endpoints for part 1 were resolution of ...

Fewer patients experienced a first hospital admission for any indication and for serious adverse events while on semaglutide.

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...

Looking to drop those stubborn pounds? The weight loss world is buzzing about a game-changing medication that's helping ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

Trying to lose weight quickly can feel like an uphill battle, but weight loss medications like Ozempic or Wegovy can speed up ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions for all causes — not just cardiac — and overall hospitalization time in people with ...